- Home
- ADIL vs RVYL Comparison
ADIL vs RVYL Comparison
Compare ADIL & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- RVYL
- Stock Information
- Founded
- ADIL 2010
- RVYL 2007
- Country
- ADIL United States
- RVYL United States
- Employees
- ADIL N/A
- RVYL N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- RVYL Professional Services
- Sector
- ADIL Health Care
- RVYL Consumer Discretionary
- Exchange
- ADIL Nasdaq
- RVYL Nasdaq
- Market Cap
- ADIL 7.6M
- RVYL 7.3M
- IPO Year
- ADIL 2018
- RVYL N/A
- Fundamental
- Price
- ADIL $0.35
- RVYL $0.28
- Analyst Decision
- ADIL Strong Buy
- RVYL Hold
- Analyst Count
- ADIL 1
- RVYL 1
- Target Price
- ADIL $8.00
- RVYL N/A
- AVG Volume (30 Days)
- ADIL 562.1K
- RVYL 1.1M
- Earning Date
- ADIL 11-12-2025
- RVYL 11-13-2025
- Dividend Yield
- ADIL N/A
- RVYL N/A
- EPS Growth
- ADIL N/A
- RVYL N/A
- EPS
- ADIL N/A
- RVYL N/A
- Revenue
- ADIL N/A
- RVYL $48,904,000.00
- Revenue This Year
- ADIL N/A
- RVYL $27.50
- Revenue Next Year
- ADIL N/A
- RVYL $35.71
- P/E Ratio
- ADIL N/A
- RVYL N/A
- Revenue Growth
- ADIL N/A
- RVYL N/A
- 52 Week Low
- ADIL $0.22
- RVYL $0.25
- 52 Week High
- ADIL $1.30
- RVYL $2.35
- Technical
- Relative Strength Index (RSI)
- ADIL 36.98
- RVYL 41.46
- Support Level
- ADIL $0.36
- RVYL $0.27
- Resistance Level
- ADIL $0.38
- RVYL $0.31
- Average True Range (ATR)
- ADIL 0.02
- RVYL 0.02
- MACD
- ADIL 0.00
- RVYL 0.00
- Stochastic Oscillator
- ADIL 14.00
- RVYL 25.60
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.